Literature DB >> 2554569

Expression of avian reticuloendotheliosis virus envelope confers host resistance.

M J Federspiel1, L B Crittenden, S H Hughes.   

Abstract

We constructed two reticuloendotheliosis virus (REV) envelope gene expression plasmids, one containing the REV-A envelope gene, the other the spleen necrosis virus (SNV) envelope gene. Cell lines were generated by transfecting each of the REV envelope plasmids into D17 cells, a canine cell line. The levels of REV envelope glycoprotein in the cell lines were assayed by immunoprecipitating the envelope glycoproteins from lysates of cells that were labeled with [35S]methionine. Virological challenge assays determined the degree of resistance of each of the cell lines to REV-A or SNV infection. The expression of either envelope gene protected the cells from infection by either REV-A or SNV virus. Several cell lines were significantly more resistant to REV infection than the parental D17 cells, and two lines were 25,000-fold more resistant, approaching the resistance of REV-infected D17 cells to reinfection. The resistant cell lines were not able to confer resistance to susceptible cells by cocultivation. The level of resistance was correlated with the uniformity of expression of the REV envelope glycoproteins by the individual cells in a cell line and not with the absolute level of expression by the population of cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554569     DOI: 10.1016/0042-6822(89)90232-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells.

Authors:  R Gautier; A Jiang; V Rousseau; R Dornburg; T Jaffredo
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.

Authors:  G Schumann; M Hermankova; K Cannon; J L Mankowski; J D Boeke
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  The chicken HMG-17 gene is dispensable for cell growth in vitro.

Authors:  Y Li; J B Dodgson
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

4.  Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.

Authors:  S L Holmen; D C Melder; M J Federspiel
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Soluble forms of the subgroup A avian leukosis virus [ALV(A)] receptor Tva significantly inhibit ALV(A) infection in vitro and in vivo.

Authors:  S L Holmen; D W Salter; W S Payne; J B Dodgson; S H Hughes; M J Federspiel
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  The RD114/simian type D retrovirus receptor is a neutral amino acid transporter.

Authors:  J E Rasko; J L Battini; R J Gottschalk; I Mazo; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Simple, automated, high resolution mass spectrometry method to determine the disulfide bond and glycosylation patterns of a complex protein: subgroup A avian sarcoma and leukosis virus envelope glycoprotein.

Authors:  Gennett M Pike; Benjamin J Madden; Deborah C Melder; M Cristine Charlesworth; Mark J Federspiel
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

8.  Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.

Authors:  Deborah C Melder; V Shane Pankratz; Mark J Federspiel
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.

Authors:  E V Barsov; S H Hughes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Mapping of receptor binding domains in the envelope protein of spleen necrosis virus.

Authors:  I Martinez; R Dornburg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.